Vergent Bioscience Revenue and Competitors
Estimated Revenue & Valuation
- Vergent Bioscience's estimated annual revenue is currently $2M per year.
- Vergent Bioscience's estimated revenue per employee is $155,000
Employee Data
- Vergent Bioscience has 13 Employees.
- Vergent Bioscience grew their employee count by 0% last year.
Vergent Bioscience's People
Name | Title | Email/Phone |
---|
Vergent Bioscience Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.8M | 50 | 9% | N/A | N/A |
#2 | $7.4M | 48 | -35% | N/A | N/A |
#3 | $0.9M | 6 | 20% | N/A | N/A |
#4 | $0.3M | 2 | -91% | N/A | N/A |
#5 | $3.6M | 23 | 5% | N/A | N/A |
#6 | $0.9M | 6 | -33% | N/A | N/A |
#7 | $5M | 32 | 3% | N/A | N/A |
#8 | $14.7M | 95 | 9% | N/A | N/A |
#9 | $14.7M | 95 | 0% | $20.5M | N/A |
#10 | $27.9M | 144 | 13% | $39.1M | N/A |
What Is Vergent Bioscience?
While the complete removal of residual cancer at the tumor margins during the surgical resection of solid tumors is closely linked with improved cure rates, it is often difficult for even experienced surgeons to distinguish cancerous tissue from normal tissue. Visual differentiation is needed at the cellular level. Our molecularly-targeted imaging molecule, VGT-309, binds to enzymes that are overexpressed in tumor tissue, activating a brightly fluorescing dye. This proprietary molecule can identify and bind to multiple cancers including lung, breast, ovarian, colorectal, and brain, among others. When injected prior to surgery, VGT-309 “lights up†cancerous tissue and gives the surgeon a clear visual guide for the removal procedure. Vergent’s approach directly addresses the clinical need and market opportunity for advanced visualization in open, laparoscopic, and robotic surgery procedures, while uniquely retaining the pricing flexibility required for success in a value-based healthcare system.
keywords:N/AN/A
Total Funding
13
Number of Employees
$2M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 13 | 0% | N/A |
#2 | $2M | 13 | 18% | N/A |
#3 | $1.4M | 13 | 8% | N/A |
#4 | $1.4M | 13 | -28% | N/A |
#5 | $1.3M | 13 | -13% | N/A |